HFMCX | TRQZX | HFMCX / TRQZX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 5 years | - |
Gain YTD | 3.168 | 8.721 | 36% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.68B | 31.4B | 18% |
Annual Yield % from dividends | 0.00 | 0.68 | - |
Returns for 1 year | 10.05 | 11.88 | 85% |
Returns for 3 years | -27.98 | -14.32 | 195% |
Returns for 5 years | -14.44 | N/A | - |
Returns for 10 years | -4.31 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 136.85 | 1.16 | +0.85% |
Franklin Biotechnology Discovery C | |||
MFLLX | 11.96 | -0.02 | -0.17% |
Morgan Stanley Inst Inception R6 | |||
HMSIX | 12.10 | -0.03 | -0.25% |
Hennessy Midstream Institutional | |||
FFBGX | 39.35 | -0.10 | -0.25% |
American Funds Global Balanced 529-F-3 | |||
GEMSX | 21.00 | -0.06 | -0.28% |
Goldman Sachs Emerging Markets Eq Svc |